| Home |
| |
Veeda Oncology® is dedicated to providing comprehensive clinical oncology research services internationally for the pharmaceutical and biotech industries. With offices in the US, Europe, India and Malaysia, we are in the unparalleled position to meet both the regional and global needs of our sponsors. Veeda Oncology® is one of the few CROs whose main focus is oncology and has its own Site Management Organization. As a result, Veeda Oncology® can meet the rigors of local and global requirements of Phase I through Phase IV programs. |
| |
Veeda Oncology® has a proven track record in conducting global oncology studies across all phases which are conducted according to ICH-GCP guidelines, meeting the highest standard of ethics and integrity, and has a strong SOP driven culture that ensures compliance with all statutory and mandatory requirements. |
| |
What sets us apart from our competitors? |
| |
- Oncology Expertise: Second to none oncology expertise having conducted 90+ cancer trials globally. Our highly qualified staff is dedicated to investigational studies and will ensure that specific study needs are met.
- Phase 1 Unit: Own a 30-bed oncology focused phase 1 facility in an academic hospital in the US with startup timelines of three (3) months.
- Site Management Organization: Manage a network of 40+ community based oncology practices through the acquisition of ION (International Oncology Network) Clinical Research, based in the US. These practices see more than 100,000 new patients annually.
- Off the Shelf Database Solutions: Utilize leading-edge, industry-recognized systems.
- Partnerships: Established relationships with oncology hospitals, which give us a unique ability to meet your patient accrual requirements.
- Cost Savings: Minimize trial costs through our oncology expertise, and strategies in meeting trial endpoints.
|
| |
Please explore our website to find out more on how we can assist you in attaining a competitive clinical advantage in the marketplace by reducing costs and expediting the product time to market… |
|